# Timing of PDA Closure and Respiratory Outcome in Premature Infants

> **NCT00802685** · NA · TERMINATED · sponsor: **University of Miami** · enrollment: 105 (actual)

## Conditions studied

- Patent Ductus Arteriosus

## Interventions

- **DRUG:** Early ibuprofen
- **OTHER:** Late ibuprofen expectant group (placebo)

## Key facts

- **NCT ID:** NCT00802685
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-11
- **Primary completion:** 2010-08
- **Final completion:** 2011-02
- **Target enrollment:** 105 (ACTUAL)
- **Why stopped:** Lack of availability of IV ibuprofen as of 8/10 due to a manufacturer's recall
- **Last updated:** 2014-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00802685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00802685, "Timing of PDA Closure and Respiratory Outcome in Premature Infants". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00802685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*